gentamicin has been researched along with Brucellosis in 72 studies
Gentamicins: A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.
Brucellosis: Infection caused by bacteria of the genus BRUCELLA mainly involving the MONONUCLEAR PHAGOCYTE SYSTEM. This condition is characterized by fever, weakness, malaise, and weight loss.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This prospective, non-randomized trial, compared the efficacy and tolerance of a doxycycline-rifampin regimen, administered for 45 days, versus doxycycline-rifampin given for 45 days plus gentamicin for the first 7-10 days, in the treatment of human brucellosis." | 9.16 | Doxycycline-rifampin versus doxycycline-rifampin-gentamicin in treatment of human brucellosis. ( Ilir, D; Ivan, V; Krsto, G; Mile, B; Nikola, L; Valerija, K, 2012) |
| "To compare the efficacy of gentamicin for 5 days plus doxycycline for 8 weeks with streptomycin for 2 weeks plus doxycycline for 45 days in the treatment of human brucellosis." | 9.14 | Comparison of the efficacy of gentamicin for 5 days plus doxycycline for 8 weeks versus streptomycin for 2 weeks plus doxycycline for 45 days in the treatment of human brucellosis: a randomized clinical trial. ( Amiri, MJ; Baiani, M; Bijani, A; Hadad, MS; Janmohammadi, N; Javanian, M; Roushan, MR, 2010) |
| "The objective of the present prospective, noncomparative, multicenter study was assess the safety and efficacy of gentamicin and doxycycline therapy for human brucellosis." | 9.08 | Treatment of human brucellosis with doxycycline and gentamicin. ( Escribano, J; Espinosa, A; Fernández, JA; Geijo, P; Martínez-Alfaro, E; Navarro, E; Sánchez, L; Solera, J, 1997) |
| "Ten patients with brucellosis were treated with azithromycin and gentamicin to assess the treatment's safety and efficacy." | 7.71 | Azithromycin and gentamicin therapy for the treatment of humans with brucellosis. ( Beato, JL; de Tomas, E; Martínez-Alfaro, E; Segura, JC; Solera, J, 2001) |
| "In view of treating intracellular Brucella infections, microspheres made of poly(lactide) (PLA) and poly(lactide-co-glycolide) (PLGA) were developed as delivery system for the cationic and highly hydrophilic antibiotic gentamicin sulphate." | 7.70 | Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections. ( Gamazo, C; Gander, B; Irache, JM; Merkle, HP; Prior, S, 2000) |
| "In the treatment of human brucellosis, antibiotic regimens containing an aminoglycoside are reportedly associated with fewer relapses." | 6.72 | Efficacy of gentamicin plus doxycycline versus streptomycin plus doxycycline in the treatment of brucellosis in humans. ( Hajiahmadi, M; Hasanjani Roushan, MR; Mohraz, M; Ramzani, A; Valayati, AA, 2006) |
| "This prospective, non-randomized trial, compared the efficacy and tolerance of a doxycycline-rifampin regimen, administered for 45 days, versus doxycycline-rifampin given for 45 days plus gentamicin for the first 7-10 days, in the treatment of human brucellosis." | 5.16 | Doxycycline-rifampin versus doxycycline-rifampin-gentamicin in treatment of human brucellosis. ( Ilir, D; Ivan, V; Krsto, G; Mile, B; Nikola, L; Valerija, K, 2012) |
| "To compare the efficacy of gentamicin for 5 days plus doxycycline for 8 weeks with streptomycin for 2 weeks plus doxycycline for 45 days in the treatment of human brucellosis." | 5.14 | Comparison of the efficacy of gentamicin for 5 days plus doxycycline for 8 weeks versus streptomycin for 2 weeks plus doxycycline for 45 days in the treatment of human brucellosis: a randomized clinical trial. ( Amiri, MJ; Baiani, M; Bijani, A; Hadad, MS; Janmohammadi, N; Javanian, M; Roushan, MR, 2010) |
| "The objective of the present prospective, noncomparative, multicenter study was assess the safety and efficacy of gentamicin and doxycycline therapy for human brucellosis." | 5.08 | Treatment of human brucellosis with doxycycline and gentamicin. ( Escribano, J; Espinosa, A; Fernández, JA; Geijo, P; Martínez-Alfaro, E; Navarro, E; Sánchez, L; Solera, J, 1997) |
| "The purpose of this study was to investigate renal function in patients with brucellosis before and at the end of gentamicin therapy." | 4.31 | Assessing the Risk of Nephrotoxicity Associated with Aminoglycosides in Brucellosis Patients: A Cross-sectional Study. ( Ataei, S; Derakhshandeh, K; Ghodsipour, Z; Keramat, F; Kord, M; Majzoobi, MM; Mohammadi, M; Mohammadi, Y; Nili-Ahmadabadi, A, 2023) |
| "Gentamicin is used to treat brucellosis, an infectious disease caused by the Brucella species but the drug faces several issues such as low efficacy, instability, low solubility, and toxicity." | 4.31 | Interaction of gentamicin and gentamicin-AOT with poly-(lactide-co-glycolate) in a drug delivery system - density functional theory calculations and molecular dynamics simulation. ( Anwar, J; Duran, S; Moin, ST, 2023) |
| " The patient was treated with doxycycline, rifampicin, and gentamicin, and underwent surgical repair of a penetrating aortic ulcer, with a good clinical recovery." | 3.80 | Brucella arteritis: clinical manifestations, treatment, and prognosis. ( Herrick, JA; Lederman, RJ; Palmore, TN; Powers, JH; Sullivan, B, 2014) |
| "The aim of this study was to assess in vitro antimicrobial susceptibility of Brucella melitensis isolates isolated from naturally infected sheep cases in an area where human brucellosis is endemic, focusing on rifampin (RIF), streptomycin (SM), ciprofloxacin (CPFX), trimethoprim/sulfamethoxazole (TMP/SMZ), gentamicin (GM) and tetracycline (TC) and on 11 other antimicrobials." | 3.79 | In vitro antimicrobial susceptibility of Brucella melitensis isolates from sheep in an area endemic for human brucellosis in Turkey. ( Ekin, IH; Ilhan, Z; Solmaz, H, 2013) |
| "Drug delivery systems containing gentamicin were studied as a treatment against experimental brucellosis in mice." | 3.74 | Poly(D,L-lactide-coglycolide) particles containing gentamicin: pharmacokinetics and pharmacodynamics in Brucella melitensis-infected mice. ( Blanco-Prieto, MJ; Campanero, MA; Gamazo, C; Lecaroz, MC; Salman, H, 2007) |
| "Neither a single intravenous or intraperitoneal dose of 67 microg of gentamicin per mouse, nor three intraperitoneal doses of 100 microg of gentamicin per mouse, reduced the Brucella infection in the spleen compared with untreated mice 1 and 3 weeks post-treatment." | 3.73 | Gentamicin-loaded microspheres for treatment of experimental Brucella abortus infection in mice. ( Gamazo, C; Gander, B; Irache, JM; Prior, S, 2005) |
| "The intracellular antibiotic efficiency of gentamicin-loaded microspheres in the context of Brucella-infected murine monocytes was examined in vitro with a view to developing improved therapies for the treatment of brucellosis." | 3.72 | Gentamicin-loaded microspheres for reducing the intracellular Brucella abortus load in infected monocytes. ( Gamazo, C; Gander, B; Irache, JM; Lecároz, C; Prior, S, 2004) |
| "Ten patients with brucellosis were treated with azithromycin and gentamicin to assess the treatment's safety and efficacy." | 3.71 | Azithromycin and gentamicin therapy for the treatment of humans with brucellosis. ( Beato, JL; de Tomas, E; Martínez-Alfaro, E; Segura, JC; Solera, J, 2001) |
| "In view of treating intracellular Brucella infections, microspheres made of poly(lactide) (PLA) and poly(lactide-co-glycolide) (PLGA) were developed as delivery system for the cationic and highly hydrophilic antibiotic gentamicin sulphate." | 3.70 | Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections. ( Gamazo, C; Gander, B; Irache, JM; Merkle, HP; Prior, S, 2000) |
| "Seventy-three cases of acute brucellosis were studied in relation to fever duration and hospital stay following different drug combinations, including gentamicin plus cotrimoxazole, rifampicin plus doxycycline, rifampicin plus cotrimoxazole, rifampicin plus tetracycline, streptomycin plus doxycycline, doxycycline plus cotrimoxazole, tetracycline plus cotrimoxazole, and tetracycline plus streptomycin." | 3.70 | Early clinical response to different therapeutic regimens for human brucellosis. ( Malik, GM, 1998) |
| "Brucellosis is among the most prevalent zoonotic infections in Middle Eastern and North African (MENA) countries, critically impacting human and animal health." | 2.82 | The perspective of antibiotic therapeutic challenges of brucellosis in the Middle East and North African countries: Current situation and therapeutic management. ( Al-Talhy, AM; Ali, H; Dadar, M; Elkharsawi, AR; Hamdy, MER; Neubauer, H; Tawab, AAAE; Wareth, G, 2022) |
| "In the treatment of human brucellosis, antibiotic regimens containing an aminoglycoside are reportedly associated with fewer relapses." | 2.72 | Efficacy of gentamicin plus doxycycline versus streptomycin plus doxycycline in the treatment of brucellosis in humans. ( Hajiahmadi, M; Hasanjani Roushan, MR; Mohraz, M; Ramzani, A; Valayati, AA, 2006) |
| "Brucellosis is the most common worldwide zoonosis which continues to remain a significant worldwide health problem and burden." | 2.55 | Brucellar Vertebral Osteomyelitis: A Case Report and Brief Review of the Literature. ( Abrantes-Figueiredo, J; Wu, U, 2017) |
| "Brucellosis is a chronic disease caused by Brucella species with a wide range of hosts, from marine mammals to terrestrial species, but with strict host preferences." | 1.91 | The canonical Brucella species-host dependency is changing, however, the antibiotic susceptibility profiles remain unchanged. ( Abay, S; Akar, M; Aydin, F; Balkan Bozlak, CE; Baykal, A; Buyuk, E; Buyuk, F; Celebi, O; Celik, E; Coskun, MR; Durhan, S; Ersoy, Y; Gulmez Saglam, A; Karakaya, E; Kayman, T; Otlu, S; Sahin, M; Saticioglu, IB, 2023) |
| "Brucellosis is one of the most common diseases that afflicts both humans and animals." | 1.56 | The expression of type II TA system genes following exposure to the sub-inhibitory concentration of gentamicin and acid stress in Brucella spp. ( Amraei, F; Lohrasbi, V; Masjedian Jazi, F; Mohammadzadeh, R; Narimisa, N; Sadeghi Kalani, B, 2020) |
| "While epididymo-orchitis is relatively common in adolescent men, when presented with a significant travel history, consideration should be given to rare causes such as this." | 1.51 | Acute epididymo-orchitis from ( Arunasalam, A; Hoh, IM; Ip, CCK; Tumali, K, 2019) |
| "Thyroiditis was diagnosed with clinical inspection and confirmed by ultrasound investigation." | 1.51 | Acute Thyroiditis Associated with Brucellosis: A Case Report. ( Bitoska, I; Bosilkovski, M; Cvetkova, M; Jakimovski, D; Poposki, K, 2019) |
| "Brucellosis has a low incidence in Chile, thus, we have a scarce data." | 1.46 | [Brucellosis in Chile: Description of a series of 13 cases]. ( Cifuentes, M; Luppi, M; Norambuena, M; Olivares, R; Silva, F; Sotomayor, C; Vidal, P, 2017) |
| "Brucellosis is one of the most common zoonotic disease affecting humans and animals and is endemic in many parts of the world including the Gulf Cooperation Council region (GCC)." | 1.42 | In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Qatar between 2014 - 2015. ( Abraham, M; Deshmukh, A; Doiphode, S; Hagen, F; Maslamani, MA; Meis, JF; Sharabasi, OA; Wilson, G, 2015) |
| "Gentamicin formulations reduced Brucella infection in experimentally infected THP-1 monocytes (>2-log10 unit reduction) when using clinically relevant concentrations (18 mg/liter)." | 1.39 | Hydrophobic gentamicin-loaded nanoparticles are effective against Brucella melitensis infection in mice. ( Blanco-Prieto, MJ; Campanero, MÁ; Elizondo, E; Gamazo, C; Gil, AG; Imbuluzqueta, E; Lana, H; Salas, D; Veciana, J; Ventosa, N, 2013) |
| "Neurobrucellosis is an uncommon complication of pediatric brucellosis." | 1.38 | Unusual presentations of pediatric neurobrucellosis. ( Budnik, I; Fuchs, I; Greenberg, D; Krymko, H; Shelef, I, 2012) |
| "Brucellosis is an important public health problem in Peru." | 1.37 | Antimicrobial susceptibility of Brucella melitensis isolates in Peru. ( Castillo, R; Cepeda, D; Chacaltana, J; Espinosa, B; Espinoza, N; González, S; Guillen, A; Hall, ER; Maves, RC; Meza, R; Núñez, G; Sánchez, L, 2011) |
| "Gentamicin (GEN) is an aminoglycoside antibiotic with a potent antibacterial activity against a wide variety of bacteria." | 1.37 | Novel bioactive hydrophobic gentamicin carriers for the treatment of intracellular bacterial infections. ( Blanco-Prieto, MJ; Elizondo, E; Gamazo, C; Imbuluzqueta, E; Moreno-Calvo, E; Veciana, J; Ventosa, N, 2011) |
| "cloxacillin, she was released from hospital with instructions to continue cloxacillin orally for another 4 weeks." | 1.30 | [Discitis in brucellosis is not responsive to anti-brucella treatment]. ( Heldenberg, D; Sevi, R, 1998) |
| "Leukopenia was found in 51% of children and anaemia in 24%." | 1.30 | Brucellosis in children in south Jordan. ( Issa, H; Jamal, M, 1999) |
| "Free gentamicin was less effective than the encapsulated antibiotic." | 1.28 | Treatment of Brucella melitensis infection in mice by use of liposome-encapsulated gentamicin. ( Crespo, F; Gómez-Fernández, JC; Hernández-Caselles, T; Vera, A; Villalaín, J, 1989) |
| " The dosage schedule used involved two intraperitoneal administrations of SPLV-entrapped aminoglycosides at three-day intervals." | 1.27 | Treatment of Brucella canis and Brucella abortus in vitro and in vivo by stable plurilamellar vesicle-encapsulated aminoglycosides. ( Fountain, AG; Fountain, MW; Lenk, RP; Shen, A; Weiss, SJ, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (12.50) | 18.7374 |
| 1990's | 11 (15.28) | 18.2507 |
| 2000's | 17 (23.61) | 29.6817 |
| 2010's | 27 (37.50) | 24.3611 |
| 2020's | 8 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Wareth, G | 1 |
| Dadar, M | 1 |
| Ali, H | 1 |
| Hamdy, MER | 1 |
| Al-Talhy, AM | 1 |
| Elkharsawi, AR | 1 |
| Tawab, AAAE | 1 |
| Neubauer, H | 1 |
| Al-Faifi, J | 1 |
| Ibrahim, ME | 1 |
| Ataei, S | 1 |
| Ghodsipour, Z | 1 |
| Keramat, F | 1 |
| Derakhshandeh, K | 1 |
| Mohammadi, Y | 1 |
| Majzoobi, MM | 1 |
| Kord, M | 1 |
| Mohammadi, M | 1 |
| Nili-Ahmadabadi, A | 1 |
| Duran, S | 1 |
| Anwar, J | 1 |
| Moin, ST | 1 |
| Celik, E | 1 |
| Kayman, T | 1 |
| Buyuk, F | 1 |
| Gulmez Saglam, A | 1 |
| Abay, S | 1 |
| Akar, M | 1 |
| Karakaya, E | 1 |
| Balkan Bozlak, CE | 1 |
| Coskun, MR | 1 |
| Buyuk, E | 1 |
| Celebi, O | 1 |
| Sahin, M | 1 |
| Saticioglu, IB | 1 |
| Durhan, S | 1 |
| Baykal, A | 1 |
| Ersoy, Y | 1 |
| Otlu, S | 1 |
| Aydin, F | 1 |
| Cvetkova, M | 1 |
| Bitoska, I | 1 |
| Poposki, K | 1 |
| Jakimovski, D | 1 |
| Bosilkovski, M | 2 |
| Amraei, F | 1 |
| Narimisa, N | 1 |
| Sadeghi Kalani, B | 1 |
| Mohammadzadeh, R | 1 |
| Lohrasbi, V | 1 |
| Masjedian Jazi, F | 1 |
| Ljubas, D | 1 |
| Lalovac, M | 1 |
| Vince, A | 1 |
| Papic, N | 1 |
| Mousavinasab, SR | 1 |
| Akhoundi-Meybodi, Z | 1 |
| Mahmoudi, L | 1 |
| Karimzadeh, I | 1 |
| Olivares, R | 1 |
| Vidal, P | 1 |
| Sotomayor, C | 1 |
| Norambuena, M | 1 |
| Luppi, M | 1 |
| Silva, F | 1 |
| Cifuentes, M | 1 |
| Shevtsov, A | 1 |
| Syzdykov, M | 1 |
| Kuznetsov, A | 1 |
| Shustov, A | 1 |
| Shevtsova, E | 1 |
| Berdimuratova, K | 1 |
| Mukanov, K | 1 |
| Ramankulov, Y | 1 |
| Valguarnera, E | 1 |
| Spera, JM | 1 |
| Czibener, C | 1 |
| Fulgenzi, FR | 1 |
| Casabuono, AC | 1 |
| Altabe, SG | 1 |
| Pasquevich, KA | 1 |
| Guaimas, F | 1 |
| Cassataro, J | 1 |
| Couto, AS | 1 |
| Ugalde, JE | 1 |
| Elzein, FE | 1 |
| Al Sherbini, N | 1 |
| Alotaibi, MM | 1 |
| Al-Hassan, WM | 1 |
| Mor, SM | 1 |
| Wiethoelter, AK | 1 |
| Massey, PD | 1 |
| Robson, J | 1 |
| Wilks, K | 1 |
| Hutchinson, P | 1 |
| Abrantes-Figueiredo, J | 1 |
| Wu, U | 1 |
| Kanji, JN | 1 |
| Saxinger, L | 1 |
| Ip, CCK | 1 |
| Tumali, K | 1 |
| Hoh, IM | 1 |
| Arunasalam, A | 1 |
| Esmaeilnejad-Ganji, SM | 1 |
| Roushan, MRH | 1 |
| Ebrahimpour, S | 1 |
| Babazadeh, A | 1 |
| Ilhan, Z | 1 |
| Solmaz, H | 1 |
| Ekin, IH | 1 |
| Imbuluzqueta, E | 2 |
| Gamazo, C | 6 |
| Lana, H | 1 |
| Campanero, MÁ | 2 |
| Salas, D | 1 |
| Gil, AG | 1 |
| Elizondo, E | 2 |
| Ventosa, N | 2 |
| Veciana, J | 2 |
| Blanco-Prieto, MJ | 3 |
| Jain-Gupta, N | 1 |
| Contreras-Rodriguez, A | 1 |
| Smith, GP | 1 |
| Garg, VK | 1 |
| Witonsky, SG | 1 |
| Isloor, S | 1 |
| Vemulapalli, R | 1 |
| Boyle, SM | 1 |
| Sriranganathan, N | 1 |
| Herrick, JA | 1 |
| Lederman, RJ | 1 |
| Sullivan, B | 1 |
| Powers, JH | 1 |
| Palmore, TN | 1 |
| Deshmukh, A | 1 |
| Hagen, F | 1 |
| Sharabasi, OA | 1 |
| Abraham, M | 1 |
| Wilson, G | 1 |
| Doiphode, S | 1 |
| Maslamani, MA | 1 |
| Meis, JF | 1 |
| Barbosa Pauletti, R | 1 |
| Reinato Stynen, AP | 1 |
| Pinto da Silva Mol, J | 1 |
| Seles Dorneles, EM | 1 |
| Alves, TM | 1 |
| de Sousa Moura Souto, M | 1 |
| Minharro, S | 1 |
| Heinemann, MB | 1 |
| Lage, AP | 1 |
| Jalan, D | 1 |
| Elhence, A | 1 |
| Elhence, P | 1 |
| Jain, P | 1 |
| Möllering, N | 1 |
| Lenhartz, H | 1 |
| Stegmann, J | 1 |
| Höger, P | 1 |
| Dayan, L | 1 |
| Deyev, S | 1 |
| Palma, L | 1 |
| Rozen, N | 1 |
| Mamalis, IP | 1 |
| Panagopoulos, MI | 1 |
| Papanastasiou, DA | 1 |
| Bricteux, G | 1 |
| Wolff, T | 1 |
| Leupold, J | 1 |
| Nüesch, R | 1 |
| Reirden, DH | 1 |
| Menchise, AN | 1 |
| Knox, B | 1 |
| Gereige, R | 1 |
| Howard, T | 1 |
| Thomas, EL | 1 |
| Connelly, R | 1 |
| Tyler, S | 1 |
| McPeak, K | 1 |
| Roushan, MR | 3 |
| Amiri, MJ | 2 |
| Janmohammadi, N | 1 |
| Hadad, MS | 1 |
| Javanian, M | 1 |
| Baiani, M | 1 |
| Bijani, A | 1 |
| Moreno-Calvo, E | 1 |
| Maves, RC | 1 |
| Castillo, R | 1 |
| Guillen, A | 1 |
| Espinosa, B | 1 |
| Meza, R | 1 |
| Espinoza, N | 1 |
| Núñez, G | 1 |
| Sánchez, L | 2 |
| Chacaltana, J | 1 |
| Cepeda, D | 1 |
| González, S | 1 |
| Hall, ER | 1 |
| Ramin, B | 1 |
| Macpherson, P | 1 |
| Mile, B | 1 |
| Valerija, K | 1 |
| Krsto, G | 1 |
| Ivan, V | 1 |
| Ilir, D | 1 |
| Nikola, L | 1 |
| Budnik, I | 1 |
| Fuchs, I | 1 |
| Shelef, I | 1 |
| Krymko, H | 1 |
| Greenberg, D | 1 |
| Salvo, S | 1 |
| Benito, R | 1 |
| de Gregorio, MA | 1 |
| Gil, J | 1 |
| Cuesta, J | 1 |
| Rubio, C | 1 |
| Durán, E | 1 |
| Karabay, O | 1 |
| Gozdas, HT | 1 |
| Olivares, D | 1 |
| Navarro-López, V | 1 |
| Serrano, R | 1 |
| López-García, F | 1 |
| Prior, S | 3 |
| Gander, B | 3 |
| Lecároz, C | 1 |
| Irache, JM | 3 |
| Hasanjani Roushan, MR | 1 |
| Mohraz, M | 1 |
| Hajiahmadi, M | 1 |
| Ramzani, A | 1 |
| Valayati, AA | 1 |
| Paitoonpong, L | 1 |
| Ekgatat, M | 1 |
| Nunthapisud, P | 1 |
| Tantawichien, T | 1 |
| Suankratay, C | 1 |
| Lecaroz, MC | 1 |
| Salman, H | 1 |
| Sarafidis, K | 1 |
| Agakidis, C | 1 |
| Diamanti, E | 1 |
| Karantaglis, N | 1 |
| Roilides, E | 1 |
| Kilicaslan, B | 1 |
| Cengiz, N | 1 |
| Pourbagher, MA | 1 |
| Cemil, T | 1 |
| Ariza, J | 1 |
| Cascio, A | 1 |
| Colmenero, JD | 2 |
| Corbel, MJ | 1 |
| Falagas, ME | 1 |
| Memish, ZA | 1 |
| Rubinstein, E | 1 |
| Sipsas, NV | 1 |
| Solera, J | 4 |
| Young, EJ | 1 |
| Pappas, G | 1 |
| Platt, P | 1 |
| Gray, J | 1 |
| Carson, P | 1 |
| Howell, GE | 1 |
| Miller, MM | 1 |
| Rowen, JI | 1 |
| Englund, JA | 1 |
| Benjamin, B | 1 |
| Espinosa, A | 2 |
| Martínez-Alfaro, E | 3 |
| Geijo, P | 1 |
| Navarro, E | 1 |
| Escribano, J | 1 |
| Fernández, JA | 1 |
| Sánchez-Tamayo, T | 1 |
| Martínez-Cortés, F | 1 |
| Moreiras, A | 1 |
| Ramos-Díaz, JC | 1 |
| García-Martín, FJ | 1 |
| Martínez Valverde, A | 1 |
| Malik, GM | 1 |
| Lozano, E | 1 |
| Castillejos, ML | 1 |
| Abad, L | 1 |
| Merkle, HP | 1 |
| Heldenberg, D | 1 |
| Sevi, R | 1 |
| Issa, H | 1 |
| Jamal, M | 1 |
| Beato, JL | 1 |
| Segura, JC | 1 |
| de Tomas, E | 1 |
| Abu-Ekteish, F | 1 |
| Kakish, K | 1 |
| Sachdev, A | 1 |
| Vohra, R | 1 |
| Bijarnia, S | 1 |
| Bastin, R | 1 |
| Charmot, G | 1 |
| Frottier, J | 1 |
| Smith, CC | 1 |
| Nigmatulin, AZ | 1 |
| Guliaev, AE | 1 |
| Gubenko, LV | 1 |
| Srymbetov, MS | 1 |
| Sharafutdinova, GI | 1 |
| Fountain, MW | 1 |
| Weiss, SJ | 1 |
| Fountain, AG | 1 |
| Shen, A | 1 |
| Lenk, RP | 1 |
| Chan, J | 1 |
| Baxter, C | 1 |
| Wenman, WM | 1 |
| Hernández-Caselles, T | 1 |
| Vera, A | 1 |
| Crespo, F | 1 |
| Villalaín, J | 1 |
| Gómez-Fernández, JC | 1 |
| al-Kasab, S | 1 |
| al-Fagih, MR | 1 |
| al-Yousef, S | 1 |
| Ali Khan, MA | 1 |
| Ribeiro, PA | 1 |
| Nazzal, S | 1 |
| al-Zaibag, M | 1 |
| Robertson, L | 1 |
| Farrell, ID | 1 |
| Hinchliffe, PM | 1 |
| Novotný, Z | 1 |
| Moeschlin, S | 1 |
6 reviews available for gentamicin and Brucellosis
| Article | Year |
|---|---|
The perspective of antibiotic therapeutic challenges of brucellosis in the Middle East and North African countries: Current situation and therapeutic management.
Topics: Animals; Anti-Bacterial Agents; Brucella melitensis; Brucellosis; Chloramphenicol; Ciprofloxacin; Do | 2022 |
Brucellar Vertebral Osteomyelitis: A Case Report and Brief Review of the Literature.
Topics: Animals; Anti-Bacterial Agents; Brucella; Brucellosis; Doxycycline; Drug Therapy, Combination; Femal | 2017 |
Brucellosis as a rare cause of olecranon bursitis: case-based review.
Topics: Anti-Bacterial Agents; Brucella melitensis; Brucellosis; Bursitis; Doxycycline; Drug Therapy, Combin | 2019 |
Update on childhood brucellosis.
Topics: Adolescent; Agglutination Tests; Anti-Bacterial Agents; Brucellosis; Child; Doxycycline; Drug Therap | 2013 |
Brucellar spondylitis: review of 35 cases and literature survey.
Topics: Adolescent; Adult; Aged; Aminoglycosides; Brucella melitensis; Brucellosis; Doxycycline; Drug Therap | 1999 |
Pneumonia as the sole presentation of brucellosis.
Topics: Anti-Bacterial Agents; Brucella melitensis; Brucellosis; Child, Preschool; Gentamicins; Humans; Male | 2001 |
5 trials available for gentamicin and Brucellosis
| Article | Year |
|---|---|
A randomized double-blinded placebo-controlled clinical trial on protective effects of pentoxifylline on gentamicin nephrotoxicity in infectious patients.
Topics: Adult; Anti-Bacterial Agents; Brucellosis; Double-Blind Method; Female; Gentamicins; Humans; Male; M | 2021 |
Comparison of the efficacy of gentamicin for 5 days plus doxycycline for 8 weeks versus streptomycin for 2 weeks plus doxycycline for 45 days in the treatment of human brucellosis: a randomized clinical trial.
Topics: Adult; Anti-Bacterial Agents; Brucellosis; Doxycycline; Drug Therapy, Combination; Female; Gentamici | 2010 |
Doxycycline-rifampin versus doxycycline-rifampin-gentamicin in treatment of human brucellosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Anti-Bacterial Agents; Brucellosis; Child; Doxy | 2012 |
Efficacy of gentamicin plus doxycycline versus streptomycin plus doxycycline in the treatment of brucellosis in humans.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Brucellosis; Doxycycline; Drug Ad | 2006 |
Treatment of human brucellosis with doxycycline and gentamicin.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Brucellosis; Child; Doxycycline; Drug Therapy, Combination | 1997 |
61 other studies available for gentamicin and Brucellosis
| Article | Year |
|---|---|
Congenital brucellosis associated with subsequent Klebsiella pneumoniae co-infection in a premature neonate: A rare case report.
Topics: Amikacin; Anti-Bacterial Agents; Brucellosis; Ciprofloxacin; Coinfection; Female; Gentamicins; Human | 2022 |
Assessing the Risk of Nephrotoxicity Associated with Aminoglycosides in Brucellosis Patients: A Cross-sectional Study.
Topics: Aged; Aminoglycosides; Anti-Bacterial Agents; Brucellosis; Creatinine; Cross-Sectional Studies; Fema | 2023 |
Interaction of gentamicin and gentamicin-AOT with poly-(lactide-co-glycolate) in a drug delivery system - density functional theory calculations and molecular dynamics simulation.
Topics: Anti-Bacterial Agents; Brucellosis; Density Functional Theory; Drug Delivery Systems; Gentamicins; G | 2023 |
The canonical Brucella species-host dependency is changing, however, the antibiotic susceptibility profiles remain unchanged.
Topics: Animals; Anti-Bacterial Agents; Brucella melitensis; Brucellosis; Cattle; Cefoperazone; Ciprofloxaci | 2023 |
Acute Thyroiditis Associated with Brucellosis: A Case Report.
Topics: Acute Disease; Anti-Bacterial Agents; Arthritis; Brucellosis; Ciprofloxacin; Gentamicins; Humans; Ma | 2019 |
The expression of type II TA system genes following exposure to the sub-inhibitory concentration of gentamicin and acid stress in Brucella spp.
Topics: Acids; Animals; Brucella; Brucella abortus; Brucella melitensis; Brucellosis; DNA, Bacterial; Female | 2020 |
Brucellosis, a forgotten cause of hepatitis in travellers.
Topics: Anti-Bacterial Agents; Bosnia and Herzegovina; Brucellosis; Cheese; Doxycycline; France; Gentamicins | 2021 |
[Brucellosis in Chile: Description of a series of 13 cases].
Topics: Adult; Aged; Brucellosis; Chile; Dairy Products; Doxycycline; Drug Therapy, Combination; Female; Gen | 2017 |
Antimicrobial susceptibility of
Topics: Anti-Bacterial Agents; Brucella melitensis; Brucellosis; Doxycycline; Drug Resistance, Multiple, Bac | 2017 |
RomA, A Periplasmic Protein Involved in the Synthesis of the Lipopolysaccharide, Tunes Down the Inflammatory Response Triggered by Brucella.
Topics: Animals; Bacterial Proteins; Brucella; Brucellosis; Gentamicins; Inflammation; Lipopolysaccharides; | 2018 |
Brucellosis accompanied by haemophagocytic lymphohistiocytosis and multiple splenic abscesses in a patient with depression.
Topics: Abscess; Adult; Anti-Bacterial Agents; Antidepressive Agents, Second-Generation; Brucellosis; Citalo | 2018 |
Pigs, pooches and pasteurisation: The changing face of brucellosis in Australia
Topics: Animals; Anorexia; Anti-Bacterial Agents; Arthralgia; Australia; Brucella abortus; Brucella canis; B | 2018 |
Topics: Aged, 80 and over; Animals; Anti-Bacterial Agents; Brucella; Brucellosis; Canada; Endocarditis; Gent | 2018 |
Acute epididymo-orchitis from
Topics: Acute Disease; Adolescent; Anti-Bacterial Agents; Australia; Brucella melitensis; Brucellosis; Doxyc | 2019 |
In vitro antimicrobial susceptibility of Brucella melitensis isolates from sheep in an area endemic for human brucellosis in Turkey.
Topics: Animals; Anti-Bacterial Agents; Brucella melitensis; Brucellosis; Ciprofloxacin; DNA Primers; Gentam | 2013 |
Hydrophobic gentamicin-loaded nanoparticles are effective against Brucella melitensis infection in mice.
Topics: Animals; Anti-Bacterial Agents; Brucella melitensis; Brucellosis; Cell Line; Drug Carriers; Female; | 2013 |
Immunotherapeutics to prevent the replication of Brucella in a treatment failure mouse model.
Topics: Animals; Anti-Bacterial Agents; Antibodies, Bacterial; Bacterial Outer Membrane Proteins; Brucella; | 2014 |
Brucella arteritis: clinical manifestations, treatment, and prognosis.
Topics: Abattoirs; Aged; Animals; Anti-Bacterial Agents; Aortic Diseases; Bacteremia; Blood Vessel Prosthesi | 2014 |
In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Qatar between 2014 - 2015.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Brucella melitensis; Brucellosis; Doxycycline; Drug Resis | 2015 |
Reduced Susceptibility to Rifampicin and Resistance to Multiple Antimicrobial Agents among Brucella abortus Isolates from Cattle in Brazil.
Topics: Animals; Anti-Bacterial Agents; Bacterial Typing Techniques; Brazil; Brucella abortus; Brucellosis; | 2015 |
A case of acute septic arthritis hip caused by Brucella melitensis in an adolescent child.
Topics: Acute Disease; Anti-Bacterial Agents; Arthritis, Infectious; Brucella melitensis; Brucellosis; Child | 2015 |
[Imported Bacteremia].
Topics: Administration, Oral; Arteries; Arthralgia; Bacteremia; Brucella melitensis; Brucellosis; Child; Dia | 2016 |
Long-standing, neglected sacroiliitis with remarked sacro-iliac degenerative changes as a result of Brucella spp. infection.
Topics: Aged; Anti-Bacterial Agents; Arthritis, Infectious; Brucellosis; Doxycycline; Female; Gentamicins; H | 2009 |
[Sacroilitis and osteomyelitis of the humeral bone du to Brucella melitensis in an adolescent].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Arthritis, Infectious; Brucella melitensis; Bruc | 2008 |
Bang! The smoker with suprapubic pain.
Topics: Abdominal Pain; Aneurysm, Infected; Anti-Bacterial Agents; Aortic Aneurysm, Abdominal; Arteriosclero | 2009 |
Index of suspicion.
Topics: Abscess; Adolescent; Anti-Bacterial Agents; Brucellosis; Cefuroxime; Child; Doxycycline; Female; Gen | 2009 |
Novel bioactive hydrophobic gentamicin carriers for the treatment of intracellular bacterial infections.
Topics: Anti-Infective Agents; Brucella melitensis; Brucellosis; Chemical Precipitation; Crystallization; Di | 2011 |
Antimicrobial susceptibility of Brucella melitensis isolates in Peru.
Topics: Anti-Infective Agents; Azithromycin; Brucella melitensis; Brucellosis; Ciprofloxacin; Doxycycline; G | 2011 |
[Brucellosis in the human].
Topics: Adult; Animals; Anti-Bacterial Agents; Brucellosis; Cheese; Delayed Diagnosis; Doxycycline; Drug The | 2011 |
Unusual presentations of pediatric neurobrucellosis.
Topics: Adolescent; Anti-Bacterial Agents; Brucellosis; Child; Doxycycline; Drug Therapy, Combination; Encep | 2012 |
[Primary brucellar psoas abscess with unexpected serological results].
Topics: Anti-Bacterial Agents; Brucella melitensis; Brucellosis; Diagnostic Errors; Doxycycline; Gentamicins | 2012 |
Brucellar joint involvement presented with chest pain.
Topics: Agglutination Tests; Anti-Bacterial Agents; Brucellosis; Doxycycline; Gentamicins; Humans; Male; Mid | 2012 |
[Brucellosis complicated by a psoas muscle abscess].
Topics: Brucellosis; Doxycycline; Drug Therapy, Combination; Gentamicins; Humans; Lumbar Vertebrae; Male; Mi | 2004 |
Gentamicin-loaded microspheres for reducing the intracellular Brucella abortus load in infected monocytes.
Topics: Animals; Anti-Bacterial Agents; Brucella abortus; Brucellosis; Cell Line; Drug Compounding; Gentamic | 2004 |
Gentamicin-loaded microspheres for treatment of experimental Brucella abortus infection in mice.
Topics: Animals; Brucella abortus; Brucellosis; Female; Gentamicins; Lactic Acid; Mice; Microspheres; Polygl | 2005 |
Brucellosis: the first case of King Chulalongkorn Memorial Hospital and review of the literature.
Topics: Animals; Anti-Bacterial Agents; Brucella melitensis; Brucellosis; Doxycycline; Drug Therapy, Combina | 2006 |
Poly(D,L-lactide-coglycolide) particles containing gentamicin: pharmacokinetics and pharmacodynamics in Brucella melitensis-infected mice.
Topics: Animals; Anti-Bacterial Agents; Brucella melitensis; Brucellosis; Disease Models, Animal; Drug Carri | 2007 |
Congenital brucellosis: a rare cause of respiratory distress in neonates.
Topics: Agriculture; Anti-Infective Agents; Brucellosis; Drug Therapy, Combination; Female; Gentamicins; Hum | 2007 |
Hepatic abscess: a rare manifestation of brucellosis in children.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Brucella melitensis; Brucellosis; Child, Preschool; Fe | 2008 |
Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations.
Topics: Animals; Anti-Bacterial Agents; Biomedical Research; Brucellosis; Developing Countries; Doxycycline; | 2007 |
Brucella endocarditis--a successfully treated case.
Topics: Adult; Brucellosis; Endocarditis, Bacterial; Gentamicins; Humans; Male; Oxytetracycline | 1980 |
Case report: brucella osteomyelitis--a difficult diagnosis.
Topics: Anti-Bacterial Agents; Brucellosis; Gentamicins; Humans; Male; Middle Aged; Osteomyelitis | 1995 |
Persistent coccobacillary sepsis in a preterm newborn.
Topics: Bacteremia; Brucella melitensis; Brucellosis; Drug Therapy, Combination; Gentamicins; Humans; Infant | 1993 |
Brucellosis presenting with cough.
Topics: Adolescent; Anti-Bacterial Agents; Antibiotics, Antitubercular; Biopsy; Bone Marrow; Brucella melite | 1995 |
Acute thrombocytopenic purpura in childhood brucellosis.
Topics: Acute Disease; Blood Platelets; Bone Marrow; Brucellosis; Child; Child, Preschool; Diagnosis, Differ | 1995 |
Failure of short-term antimicrobial therapy in childhood brucellosis.
Topics: Brucellosis; Child; Child, Preschool; Doxycycline; Drug Administration Schedule; Drug Therapy, Combi | 1997 |
Early clinical response to different therapeutic regimens for human brucellosis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Bacterial Agen | 1998 |
Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections.
Topics: Biocompatible Materials; Brucellosis; Drug Compounding; Gentamicins; Lactic Acid; Microbial Sensitiv | 2000 |
[Discitis in brucellosis is not responsive to anti-brucella treatment].
Topics: Adolescent; Brucellosis; Cloxacillin; Discitis; Doxycycline; Drug Therapy, Combination; Female; Gent | 1998 |
Brucellosis in children in south Jordan.
Topics: Adolescent; Anemia; Animals; Anti-Bacterial Agents; Arthralgia; Brucellosis; Child; Child, Preschool | 1999 |
Azithromycin and gentamicin therapy for the treatment of humans with brucellosis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Brucellosis; Child; Drug Therapy, Combinatio | 2001 |
Acute brucellosis of childhood: a case report with unusual features.
Topics: Acute Disease; Agglutination Tests; Anti-Bacterial Agents; Anti-Infective Agents; Brucellosis; Child | 2001 |
[Infectious and parasitic diseases: overview of current status in 1979].
Topics: Anti-Bacterial Agents; Brucellosis; Cephalosporins; Drug Combinations; France; Gentamicins; Hepatiti | 1979 |
Treatment of human brucellosis.
Topics: Acute Disease; Anti-Bacterial Agents; Brucellosis; Chronic Disease; Doxycycline; Drug Combinations; | 1976 |
[Antibiotic binding by leukocytes from brucellosis patients].
Topics: Adult; Anti-Bacterial Agents; Brucellosis; Erythromycin; Female; Gentamicins; Humans; Leukocytes; Ma | 1990 |
Treatment of Brucella canis and Brucella abortus in vitro and in vivo by stable plurilamellar vesicle-encapsulated aminoglycosides.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Brucella; Brucella abortus; Brucellosis; Cells, Cul | 1985 |
Brucellosis in an inuit child, probably related to caribou meat consumption.
Topics: Animals; Brucellosis; Canada; Child; Drug Therapy, Combination; Food Contamination; Gentamicins; Hum | 1989 |
Treatment of Brucella melitensis infection in mice by use of liposome-encapsulated gentamicin.
Topics: Amines; Animals; Brucella; Brucellosis; Cholesterol; Drug Carriers; Gentamicins; Liposomes; Macropha | 1989 |
Brucella infective endocarditis. Successful combined medical and surgical therapy.
Topics: Adult; Aortic Valve; Brucellosis; Combined Modality Therapy; Drug Combinations; Echocardiography; En | 1988 |
The sensitivity of Brucella abortus to chemotherapeutic agents.
Topics: Ampicillin; Brucella abortus; Brucellosis; Carbenicillin; Drug Synergism; Gentamicins; Humans; Kanam | 1973 |
[Clinical experience with the broadspectrum antibiotic gentamycin (1969-1970)].
Topics: Adult; Bronchitis; Bronchopneumonia; Brucellosis; Gentamicins; Humans; Injections, Intramuscular; Ki | 1972 |